Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Resonance Health Ltd ( (AU:RHT) ) just unveiled an update.
Resonance Health Ltd has released updated shareholder information in compliance with ASX Listing Rule 4.10. This update includes details on corporate governance, securities distribution, and the top twenty security holders. The announcement replaces previous shareholder information from the company’s annual report and reflects the company’s commitment to transparency and regulatory compliance.
More about Resonance Health Ltd
Resonance Health is an Australian healthcare technology and services company that provides globally recognized quantitative assessments for managing human diseases. The company offers Software-as-Medical Devices (SaMDs) that have received regulatory clearances in the USA, Europe, UK, and Australia. Their products, which include FerriScan®, FerriSmart®, HepaFatScan®, HepaFatSmart®, LiverSmart®, and CardiacT2*, are used in clinical trials and endorsed by leading physicians worldwide.
Average Trading Volume: 358,270
Technical Sentiment Signal: Sell
Current Market Cap: A$18.36M
For detailed information about RHT stock, go to TipRanks’ Stock Analysis page.